Penumbra, Inc.
PEN
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components aā¦ read more
Healthcare
Medical Devices
10 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$311.44
Price+2.76%
$8.37
1Y
Price
Market Cap
$12.197b
Large
Price/Earnings 3y Avg5y Avg
74.5x
Premium
Premium
Financials Overview
Key metrics over the past few years+15.6%
EBITDA Margin+12.9%
Net Profit Margin+11.9%
Free Cash Flow MarginRevenue
$1.334b
+11.7%
1y CAGR+16.5%
3y CAGR+15.7%
5y CAGREarnings
$164.027m
+1070.6%
1y CAGR+1876.4%
3y CAGR+1372.8%
5y CAGREPS
$4.18
+1061.1%
1y CAGR+1905.5%
3y CAGR+1386.3%
5y CAGRBook Value
$1.359b
$1.744b
Assets$385.673m
Liabilities$217.045m
DebtDebt to Assets
12.4%
1.1x
Debt to EBITDAFree Cash Flow
$152.621m
+3.6%
1y CAGR+97.5%
3y CAGR-62.3%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company